Nautilus Biotechnology (NASDAQ:NAUT) reported first-quarter 2026 results and highlighted progress toward its planned ...

Earlier today, Nautilus Biotechnology released financial results for the quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's ...

Regeneron Pharmaceuticals' board has added $3 billion to the biotechnology company's stock-buyback program. Regeneron on Wednesday said the new authorization adds to the $688 million remaining under ...

Huntsville is big on defense in more ways than aerospace. Why it matters: The workforce and research engine created by ...

Trade ministers of Korea and Qatar agreed Wednesday to expand the two countries' cooperation in advanced industries, ...

Dual-targeted allogeneic CAR-T therapy demonstrates immune-reset mechanism and durable remission in system lupus ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2026. First ...

Vivacta Biotechnology (Shanghai) Co., Ltd. ("Vivacta" or "Vivacta Bio"), an innovative biotechnology company focused on ...

On April 2, Beam Therapeutics Inc. (NASDAQ:BEAM) released results from its Phase 1/2 BEACON study for ristoglogene ...

The proposal, spearheaded by EU Health Commissioner Olivér Várhelyi, is intended to strengthen Europe’s life sciences sector, ...

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

The Indian National Science Academy has selected Prof Appa Rao Podile, former University of Hyderabad Vice-Chancellor, for its Senior Scientist position. The three-year role recognises his ...